andrew huberman on glp 1 “Everyone Should be a GLP-1 Medication”, “Should everyone just be Andrew Huberman on Ozempic and

GLP-1 receptor agonists are generally well tolerated, but gastrointestinal side effects are common, particularly when initiating treatment or increasing doses

Muraoka A, Suzuki M, Hamaguchi T, et al

Recovery without immunosuppressant treatment and the long interval between drug initiation and onset of the eruption suggests a temporary immunologic reactivity and/or restoration by spontaneous removal of the causative agent

Subcutaneous injection into the fat layer bypasses the digestive tract completely, preventing stomach acids and liver metabolism from destroying the delicate peptide structure

10.1038/nrm2468 Nat